With the ongoing COVID-19 (Coronavirus Disease 2019) pandemic, caused by the novel coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), there is a need for sensitive, specific, and affordable diagnostic tests to identify infected individuals, not all of whom are symptomatic. The most sensitive test involves the detection of viral RNA using RT-qPCR (quantitative reverse transcription PCR), with many commercial kits now available for this purpose. However, these are expensive, and supply of such kits in sufficient numbers cannot always be guaranteed. We therefore developed a multiplex assay using well-established SARS-CoV-2 targets alongside a human cellular control ( RPP30 ) and a viral spike-in control (Phocine Herpes Virus 1 [PhHV-1]), which monitor sample quality and nucleic acid extraction efficiency, respectively. Here, we establish that this test performs as well as widely used commercial assays, but at substantially reduced cost. Furthermore, we demonstrate >1,000-fold variability in material routinely collected by combined nose and throat swabbing and establish a statistically significant correlation between the detected level of human and SARS-CoV-2 nucleic acids. The inclusion of the human control probe in our assay therefore provides a quantitative measure of sample quality that could help reduce false-negative rates. We demonstrate the feasibility of establishing a robust RT-qPCR assay at approximately 10% of the cost of equivalent commercial assays, which could benefit low-resource environments and make high-volume testing affordable. Better and cheaper SARS-CoV-2 qRT-PCR tests are needed, but it is known that human and viral nucleic acid quantities in swab samples correlate, showing the importance of a human quality control probe. This study describes multiplex assays that perform equally well to commercial tests, but at ~10% of the cost.
【초록키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, Coronavirus disease 2019, coronavirus, pandemic, feasibility, diagnostic test, severe acute respiratory syndrome Coronavirus, coronavirus 2, respiratory syndrome coronavirus 2, Novel coronavirus, nucleic acid, RT-qPCR, Viral, Multiplex assay, nucleic acids, diagnostic tests, symptomatic, target, Viral RNA, Quality control, respiratory, swabbing, correlation, reverse transcription PCR, Quantitative, cellular, Efficiency, nose and throat, can not, (coronavirus disease 2019, PCR tests, acute respiratory syndrome coronavirus, infected individuals, novel coronavirus SARS-CoV-2, Variability, viral nucleic acid, nucleic acid extraction, help, supply, false-negative rates, material, RPP30, swab samples, viral spike, MONITOR, probe, Inclusion, benefit, SARS-CoV-2 qRT-PCR, robust, swab sample, identify, collected, caused, assays, reduced, provide, reduce, statistically significant, Better, Herpe, 【제목키워드】 SARS-CoV-2 detection, multiplex RT-qPCR,